HIGHLIGHTS
- who: Mihaela Rata from the wns Road, PT, Sutton, London, UK have published the research work: Implementation of whole-body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma, in the Journal: (JOURNAL)
- what: The authors report on the first study to embed standardised WB-MRI within a prospective multicentre myeloma clinical trial (IMAGIMM trial sub-study of OPTIMUM/MUKnine) to explore the use of WB-MRI to detect minimal residual disease after treatment. The work concentrated on the functional WBMRI sequences only, as these two sequences are essential . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.